Skip to main content

Table 1 Changes in [25(OH)D] following a single dose of 70,000 IU vitamin D3 in non-pregnant and pregnant women in Dhaka, Bangladesh a

From: Pharmacokinetics of a single oral dose of vitamin D3 (70,000 IU) in pregnant and non-pregnant women

 

All participants

Non-pregnant

Pregnant

P b

N (all participants)

61

34

27

 

Baseline [25(OH)D] (N=61)

Mean [95% CI]

47 [42, 52]

54 [47, 62]

39 [34, 45]

0.010

Range

21, 96

27, 96

21, 95

 

Δ[25(OH)D], Mean [95% CI], nmol/L

Day 2 (N=27)

20 [15,25]

24 [17, 33]

15 [11,22]

0.037

Day 4 (N=27)

23 [18, 30]

24 [17, 34]

23 [16, 32]

0.800

Day 7 (N=29)

26 [21, 33]

25 [18, 34]

28 [20, 40]

0.134

Day 21 (N=14)

25 [18, 35]

21 [14, 33]

32 [20, 51]

0.003

Day 56 (N=12)

16 [11,23]

14 [9,21]

20 [12, 33]

0.101

Participants in single-dose only groups

N (% followed more than 7 days)

31 (51%)

18 (53%)

13 (48%)

 

# Specimens per participant

Median

6

6

6

 

Range

3, 6

3, 6

3, 6

 

Baseline [25(OH)D] (N=31)

Mean [95% CI]

48 [41, 56]

52 [42, 64]

43 [34, 55]

0.224

Range

21, 96

27, 96

21, 95

 

Tmax, days (N=31)

Mean [95% CI]

11 [7,18]

9 [4,17]

17 [10,29]

0.134

Range

2, 70

2, 70

2, 70

 

Cmax, nmol/L (N=31)

Mean [95% CI]

85 [77, 93]

87 [75, 101]

82 [72, 92]

0.500

Range

51, 164

51, 164

52, 116

 

ΔCmax, nmol/L (N=31)

Mean [95% CI]

30 [23, 39]

28 [18, 42]

33 [24, 46]

0.486

Range

2, 87

2, 87

9, 52

 

Area under the curve, nmol·d/L c

AUC56/70, Mean (N=30)

935

910

969

0.863

[95% CI]

[651, 1343]

[531, 1559]

[563, 1668]

AUC28/35, Mean (N=31)

591

562

632

0.672

[95% CI]

[448, 780]

[383, 823]

[398, 1003]

ΔCavg 28/35 per mg dose d (nmol/L/mg)

[95% CI]

12 [10,15]

12 [8,15]

14 [10,18]

0.370

  1. a. [25(OH)D] summary measures are geometric means with exponentiated 95% confidence intervals, unless otherwise indicated.
  2. b. One-way analysis of variance (ANOVA) test for difference between non-pregnant and pregnant groups.
  3. c. AUC was only estimated using data from participants with follow-up to the end of the interval of interest (i.e., 28/35 days or 56/70 days).
  4. d. Average [25(OH)D] over the first 28 or 35 days, per mg of the single vitamin D3 dose. Arithmetic means and 95% confidence intervals reported because these estimates had an approximately normal distribution.